Quercetin alleviates neonatal hypoxic-ischemic brain injury by inhibiting microglia-derived oxidative stress and TLR4-mediated inflammation

Kai Le,Zhiping Song,Jie Deng,Xin Peng,Jun Zhang,Liang Wang,Lu Zhou,Haidi Bi,Zhengyu Liao,Zhen Feng
DOI: https://doi.org/10.1007/s00011-020-01402-5
Abstract:Objective and design: Microglia stimulated by oxygen glucose deprivation (OGD) were treated with quercetin to investigate the effect on oxidative stress and the inflammatory response and to explore whether toll-like receptor 4 (TLR4) signaling was involved. In addition, the effect of quercetin on the neurological functions of neonatal mice with hypoxic-ischemic brain injury (HIBI) was examined. Materials and subjects: Mouse BV2 microglial cells and postnatal day 7 neonatal mice were used. Treatment: A predetermined concentration of quercetin was used in cell experiments. Quercetin was injected i.p. (50 mg/kg) at three time points after HI insult: 0, 24, and 48 h. Methods: Cell viability assay, Western blotting, qRT-RCR, ELISA, HIBI model construction and behavioral tests. Results: This study first showed that quercetin protected BV2 cells from OGD-induced damage and reversed the changes in microglial oxidative stress-related molecules. Second, quercetin inhibited OGD-induced expression of inflammatory factors in BV2 cells and suppressed TLR4/MyD88/NF-κB signaling. Finally, quercetin was disclosed to be effective in mitigating cerebral infarct volume and cognitive and motor function deficits in HIBI mice. Conclusion: These results suggest that the neuroprotective effect of quercetin in HIBI mice is partially due to the inhibition of oxidative stress and TLR4-mediated inflammatory responses in activated microglia.
What problem does this paper attempt to address?